Cargando…
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning
BACKGROUND: Survivors of acute COVID-19 often suffer prolonged, diffuse symptoms post-infection, referred to as “Long-COVID”. A lack of Long-COVID biomarkers and pathophysiological mechanisms limits effective diagnosis, treatment and disease surveillance. We performed targeted proteomics and machine...
Autores principales: | Patel, Maitray A., Knauer, Michael J., Nicholson, Michael, Daley, Mark, Van Nynatten, Logan R., Cepinskas, Gediminas, Fraser, Douglas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942653/ https://www.ncbi.nlm.nih.gov/pubmed/36809921 http://dx.doi.org/10.1186/s10020-023-00610-z |
Ejemplares similares
-
Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism
por: Patel, Maitray A., et al.
Publicado: (2022) -
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function
por: Iosef, Cristiana, et al.
Publicado: (2023) -
Novel plasma protein biomarkers from critically ill sepsis patients
por: Van Nynatten, Logan R., et al.
Publicado: (2022) -
Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020) -
A novel multiplex biomarker panel for profiling human acute and chronic kidney disease
por: Van Nynatten, Logan R., et al.
Publicado: (2023)